1. Home
  2. BARK vs KRRO Comparison

BARK vs KRRO Comparison

Compare BARK & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BARK Inc.

BARK

BARK Inc.

N/A

Current Price

$0.63

Market Cap

92.7M

ML Signal

N/A

Logo Korro Bio Inc.

KRRO

Korro Bio Inc.

N/A

Current Price

$10.61

Market Cap

109.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BARK
KRRO
Founded
2011
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Department/Specialty Retail Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
92.7M
109.7M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
BARK
KRRO
Price
$0.63
$10.61
Analyst Decision
Buy
Buy
Analyst Count
2
12
Target Price
$2.50
$34.80
AVG Volume (30 Days)
893.9K
204.9K
Earning Date
02-05-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$6,392,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2.43
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
181.46
52 Week Low
$0.53
$5.20
52 Week High
$1.48
$55.89

Technical Indicators

Market Signals
Indicator
BARK
KRRO
Relative Strength Index (RSI) 28.04 43.23
Support Level $0.53 $10.55
Resistance Level $0.86 $14.96
Average True Range (ATR) 0.05 0.87
MACD -0.02 -0.15
Stochastic Oscillator 8.88 2.55

Price Performance

Historical Comparison
BARK
KRRO

About BARK BARK Inc.

BARK Inc is a vertically integrated, omnichannel brand serving dogs across two key categories: toys & accessories and consumables. It serves dogs nationwide with monthly subscription services, BarkBox and Super Chewer; e-commerce experience on BarkShop.com; custom collections via its retail partner network, including Target and Amazon; wellness products that meet dogs' needs with BARK Bright; and a personalized meal delivery service for dogs BARK Eats. The company's reportable segments are; Direct to Consumer (D2C), and Commerce. The majority of its revenue is generated from the Direct to Consumer segment which derives revenue from the sale of toys & accessories and consumables through BarkBox, Super Chewer, and the company's consumables website.

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.

Share on Social Networks: